| [1] |
Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
|
| [2] |
Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1.Introduction-GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol, 2011, 64(4): 383-394.
|
| [3] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [4] |
赫捷,魏文强. 2019中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2021.
|
| [5] |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: A pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555-e567.
|
| [6] |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
|
| [7] |
Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(3): 233-254.
|
| [8] |
Zeng H, Ran X, An L, et al. Disparities in stage at diagnosis for five common cancers in China: A multicentre, hospital-based, observational study[J]. Lancet Public Health, 2021, 6(12): e877-e887.
|
| [9] |
Sung J, Chiu HM, Lieberman D, et al. Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance[J]. Gut, 2022, 71(11): 2152-2166.
|
| [10] |
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中华肿瘤杂志, 2021, 43(1): 16-38.
|
| [11] |
Kaminski MF, Robertson DJ, Senore C, et al. Optimizing the Quality of Colorectal Cancer Screening Worldwide[J]. Gastroenterology, 2020, 158(2): 404-417.
|
| [12] |
Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer[J]. Gastroenterology, 2014, 147(4): 903-924.
|
| [13] |
中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜学专业委员会. 中国早期结直肠癌筛查及内镜诊治指南(2014,北京) [J]. 中华医学杂志, 2015, 95(28): 2235-2252.
|
| [14] |
中国抗癌协会大肠癌专业委员会中国结直肠肿瘤早诊筛查策略制订专家组. 中国结直肠肿瘤早诊筛查策略专家共识[J]. 中华胃肠外科杂志, 2018, 21(10): 1081-1086.
|
| [15] |
董志伟, 乔友林, 王贵齐, 等. 癌症早诊早治工作评价指标的探讨[J]. 中国肿瘤, 2010, 19(10): 633-638.
|
| [16] |
吴春晓, 顾凯, 龚杨明, 等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
|
| [17] |
Lew JB, St John D, Xu XM, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: A modelling study[J]. Lancet Public Health, 2017, 2(7): e331-e340.
|
| [18] |
Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China[J]. Gut, 2019, 68(8): 1450-1457.
|
| [19] |
Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease[J]. Gastroenterology, 2010, 138(2): 746-774, 774. e1-4; quiz e12-13.
|
| [20] |
Update on the paris classification of superficial neoplastic lesions in the digestive tract[J]. Endoscopy, 2005, 37(6): 570-578.
|
| [21] |
Nougaret S, Reinhold C, Mikhael HW, et al. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"?[J]. Radiology, 2013, 268(2): 330-344.
|
| [22] |
Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer[J]. Int J Clin Oncol, 2020, 25(1):1-42.
|
| [23] |
Gong W, Lv N, Wang B, et al. Risk of ulcerative colitis-associated colorectal cancer in China: A multi-center retrospective study[J]. Dig Dis Sci, 2012, 57(2): 503-507.
|
| [24] |
中国抗癌协会大肠癌专业委员会遗传学组. 遗传性结直肠癌临床诊治和家系管理中国专家共识[J]. 实用肿瘤杂志, 2018, 33(1): 3-16.
|
| [25] |
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes[J]. Am J Gastroenterol, 2015, 110(2): 223-262; quiz 263.
|
| [26] |
Buess G, Mentges B, Manncke K, et al. Technique and results of transanal endoscopic microsurgery in early rectal cancer[J]. Am J Surg, 1992, 163(1): 63-70.
|
| [27] |
林国乐, 邱辉忠, 周皎琳, 等. 经肛门内镜微创手术的适应证与并发症[J/CD]. 中华结直肠疾病电子杂志, 2015, (5): 521-525.
|
| [28] |
Benson AB, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018[J]. J Natl Compr Canc Netw, 2018, 16(4): 359-369.
|
| [29] |
中国NOSES联盟, 中国医师协会结直肠肿瘤专业委员会NOSES专委会. 结直肠肿瘤经自然腔道取标本手术专家共识(2017) [J/CD]. 中华结直肠疾病电子杂志, 2017, 6(4): 266-272.
|
| [30] |
Liu H, Zeng Z, Zhang H, et al. Morbidity, mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short-term outcomes from a multicenter randomized controlled trial[J]. Ann Surg, 2023, 277(1): 1-6.
|
| [31] |
Motson RW, Whiteford MH, Hompes R, et al. Current status of trans-anal total mesorectal excision (TaTME) following the Second International Consensus Conference[J]. Colorectal Dis, 2016, 18(1): 13-18.
|
| [32] |
中华人民共和国国家卫生健康委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2020年版)[J].中国实用外科杂志, 2020, 40(6): 601-625.
|
| [33] |
He X, Hang D, Wu K, et al. Long-term risk of colorectal cancer after removal of conventional adenomas and serrated polyps[J]. Gastroenterology, 2020, 158(4): 852-861.e4.
|
| [34] |
Kahi CJ, Myers LJ, Stump TE, et al. Tailoring surveillance colonoscopy in patients with advanced adenomas[J]. Clin Gastroenterol Hepatol, 2022, 20(4):847-854. e1.
|
| [35] |
Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer[J]. Gastroenterology, 2020, 158(4): 1131-1153. e5.
|
| [36] |
Rutter MD, East J, Rees CJ, et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines[J]. Gut, 2020, 69(2): 201-223.
|
| [37] |
Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement[J]. J Clin Oncol, 2013, 31(35): 4465 - 4470.
|
| [38] |
Heitzer E, Haque IS, Roberts C, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology[J]. Nat Rev Genet, 2019, 20(2): 71-88.
|
| [39] |
Tie J, Cohen JD, Wang Y, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage Ⅲ colon cancer[J]. JAMA Oncol, 2019, 5(12): 1710-1717.
|
| [40] |
Reinert T, Henriksen TV, Christensen E, et al. Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages Ⅰ to Ⅲ colorectal cancer[J]. JAMA Oncol, 2019, 5(8): 1124-1131.
|
| [41] |
Chen G, Peng J, Xiao Q, et al. Postoperative circulating tumor DNA as markers of recurrence risk in stagesⅡ toⅢ colorectal cancer[J]. J Hematol Oncol, 2021, 14(1):80.
|